KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biogen (BIIB) Leases (2016 - 2025)

Biogen (BIIB) has 16 years of Leases data on record, last reported at $265.4 million in Q4 2025.

  • For Q4 2025, Leases fell 25.53% year-over-year to $265.4 million; the TTM value through Dec 2025 reached $265.4 million, down 25.53%, while the annual FY2025 figure was $265.4 million, 25.53% down from the prior year.
  • Leases reached $265.4 million in Q4 2025 per BIIB's latest filing, down from $330.5 million in the prior quarter.
  • Across five years, Leases topped out at $460.9 million in Q3 2023 and bottomed at $265.4 million in Q4 2025.
  • Average Leases over 5 years is $378.4 million, with a median of $384.8 million recorded in 2021.
  • Peak YoY movement for Leases: grew 14.14% in 2023, then decreased 25.53% in 2025.
  • A 5-year view of Leases shows it stood at $375.4 million in 2021, then rose by 7.59% to $403.9 million in 2022, then increased by 3.99% to $420.0 million in 2023, then dropped by 15.14% to $356.4 million in 2024, then fell by 25.53% to $265.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $265.4 million in Q4 2025, $330.5 million in Q3 2025, and $334.5 million in Q2 2025.